Clinical Trials Browser

Phase 1/2 × Dosage Forms × Clear all

NCT05309668 2025-12-18

SPRINKLE

Phase 1/2 Active not recruiting

36 enrolled 37 charts

Neurofibromatosis 1

NCT03593187 2025-11-20

GENHIV

Phase 1/2 Completed

Lymphoma